These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38410750)

  • 1. Case report: If it is not asthma-think of lymphangioleiomyomatosis in younger female patients.
    Kirkeby MH; Bendstrup E; Rose HK
    Front Med (Lausanne); 2024; 11():1328471. PubMed ID: 38410750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
    Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
    Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangioleiomyomatosis: differential diagnosis and optimal management.
    Xu KF; Lo BH
    Ther Clin Risk Manag; 2014; 10():691-700. PubMed ID: 25187723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
    Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
    Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
    Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
    Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A woman with dyspnea and recurrent pneumothorax: when dyspnea is not asthma.
    Chidharla A; Sehring M; Ascencio MA; Chittivelu S
    J Community Hosp Intern Med Perspect; 2020 Aug; 10(4):334-337. PubMed ID: 32850091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of transbronchial lung biopsy for the diagnosis of lymphangioleiomyomatosis: A report of 24 consecutive patients.
    Koba T; Arai T; Kitaichi M; Kasai T; Hirose M; Tachibana K; Sugimoto C; Akira M; Hayashi S; Inoue Y
    Respirology; 2018 Mar; 23(3):331-338. PubMed ID: 28960664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise Incremental Dose Schedule of Sirolimus Is Successfully Tolerated by a Patient With Lymphangioleiomyomatosis Who Was Initially Allergic to mTOR Inhibitors.
    Seyama K; Komiyama E; Tsuchihashi H; Okura MK; Sekimoto Y; Mitsuishi Y
    Cureus; 2024 Apr; 16(4):e58805. PubMed ID: 38784348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis.
    Lu C; Lee HS; Pappas GP; Dilling DF; Burger CD; Shifren A; Veeraraghavan S; Chapman JT; Parambil J; Ruoss SJ; Young LR; Hammes SR; Kopras EJ; Roads T; Krischer JP; McCormack FX;
    Ann Am Thorac Soc; 2017 Jun; 14(6):919-928. PubMed ID: 28570161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
    Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
    Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphangioleiomyomatosis.
    Doubková M; Štefániková M; Čan V; Merta Z; Svoboda M
    Klin Onkol; 2019; 32(5):367-374. PubMed ID: 31610670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary lymphangioleiomyomatosis associated with aggressive renal angiomyolipoma.
    Cooper A; Baugh L; Kelley S; Huang H; Guileyardo J
    Proc (Bayl Univ Med Cent); 2018 Jan; 31(1):81-83. PubMed ID: 29686563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spindle cell lesion on fine needle aspiration as an initial step for diagnosis of lymphangioleiomyomatosis: Report of a rare case.
    Manukyan I; Sidawy M; DeBrito P
    Diagn Cytopathol; 2021 Sep; 49(9):E352-E355. PubMed ID: 34000096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
    Sobiecka M
    Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor-D is increased in serum of patients with lymphangioleiomyomatosis.
    Seyama K; Kumasaka T; Souma S; Sato T; Kurihara M; Mitani K; Tominaga S; Fukuchi Y
    Lymphat Res Biol; 2006; 4(3):143-52. PubMed ID: 17034294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of sirolimus in the treatment of lymphangioleiomyomatosis: favorable responses in patients with different extrapulmonary manifestations.
    Freitas CS; Baldi BG; Araújo MS; Heiden GI; Kairalla RA; Carvalho CR
    J Bras Pneumol; 2015; 41(3):275-80. PubMed ID: 26176526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus treatment of abdominal lymphangioleiomyoma in five women with sporadic lymphangioleiomyomatosis.
    Mohammadieh AM; Bowler SD; Silverstone EJ; Glanville AR; Yates DH
    Med J Aust; 2013 Jul; 199(2):121-3. PubMed ID: 23879512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A rare cause of edema: sporadic lymphangioleiomyomatosis].
    Frank H; Weiss W
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1892-5. PubMed ID: 24022453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
    Wang Q; Luo M; Xiang B; Chen S; Ji Y
    Respir Res; 2020 Feb; 21(1):55. PubMed ID: 32059669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUCCESSFUL TREATMENT OF PULMONARY AND LYMPHATIC MANIFESTATIONS OF LYMPHANGIOLEIOMYOMATOSIS WITH SIROLIMUS.
    Hecimovic A; Jakopovic M; Pavlisa G; Jankovic M; Vukic-Dugac A; Redzepi G; Brcic L; Samarzija M; Gupta N
    Lymphology; 2015 Jun; 48(2):97-102. PubMed ID: 26714374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.